Oxidative Phosphorylation |
5.39 |
−1.16 |
4.71 |
−1.67 |
Hepatic Fibrosis Signaling Pathway |
2.41 |
−1.60 |
1.57 |
−2.31 |
Wound Healing Signaling Pathway |
1.53 |
−2.53 |
1.61 |
−3.16 |
Estrogen Receptor Signaling |
3.14 |
−2.11 |
1.89 |
−2.89 |
Macropinocytosis Signaling |
2.45 |
−2.45 |
2.24 |
−2.45 |
GP6 Signaling Pathway |
2.14 |
−1.63 |
0.91 |
−2.12 |
Pulmonary Fibrosis Idiopathic Signaling Pathway |
1.23 |
−2.31 |
1.00 |
−2.53 |
G Beta Gamma Signaling |
2.11 |
−2.65 |
0.91 |
−2.65 |
Gαi Signaling |
1.90 |
−2.45 |
1.51 |
−2.45 |
Regulation of eIF4 and p70S6K Signaling |
1.67 |
−2.45 |
1.73 |
−2.45 |
p70S6K Signaling |
1.90 |
−2.45 |
1.39 |
−2.24 |
Thrombin Signaling |
1.51 |
−2.83 |
0.91 |
−2.65 |
NF-κB Activation by Viruses |
1.89 |
−2.24 |
1.41 |
−2.24 |
Regulation of Cellular Mechanics by Calpain Protease |
2.12 |
−1.89 |
0.91 |
−2.45 |
Glioma invasiveness Signaling |
1.89 |
−2.45 |
0.63 |
−2.24 |
HGF Signaling |
1.16 |
−2.45 |
0.28 |
−2.45 |
UVA-induced MAPK signaling |
1.13 |
−2.00 |
1.13 |
−2.00 |
CDK5 Signaling |
1.51 |
−2.24 |
0.26 |
−2.24 |
PEDF Signaling |
1.14 |
−1.63 |
0.71 |
−2.24 |
Fc Epsilon RI signaling |
−1.13 |
−2.-24 |
0.38 |
−2.-24 |
Glycolysis I |
−3.46 |
1.41 |
−3.61 |
2.83 |
PTEN Signaling |
−1.73 |
2.65 |
−1.16 |
2.45 |
Epithelial Adherens Junction Signaling |
−2.20 |
1.27 |
−2.35 |
2.00 |
CLEAR Signaling Pathway |
−1.67 |
1.70 |
−1.41 |
2.45 |
Gluconeogenesis I |
−2.11 |
2.45 |
−2.11 |
2.83 |
Sirtuin Signaling Pathway |
−0.85 |
−2.32 |
−1.26 |
−0.83 |
Apotosis |
1.25 |
−0.94 |
2.19 |
−2.82 |